Physician profile
Michael Yoo
NPI 1194915868
$3,876.69
in general payments reported to CMS, 2019-2025
11 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $526 · 2020: $93.25 · 2022: $159 · 2023: $2,969 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,292 · Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,292.31 |
| Food and Beverage | $806.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,870.82 | 2023 | Natrelle Saline-Filled Breast Implants, Strattice Reconstructive Tissue Matrix Bps |
| Sientra, INC. | $225.21 | 2019-2020 | |
| Stryker Corporation | $220.14 | 2019 | |
| Innovation Technologies INC | $116.25 | 2022 | |
| Axogen | $97.70 | 2023 | Avance Nerve Graft |
| Allergan, INC. | $92.90 | 2019-2022 | |
| Integra Lifesciences Corporation | $90.26 | 2025 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Solta Medical, A Division of Bausch Health US, LLC | $81.09 | 2019 | |
| Motiva USA, LLC | $39.63 | 2025 | |
| Galderma Laboratories, L.P. | $21.38 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $21.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.